MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

Search

Atara Biotherapeutics Inc

Closed

SectorHealthcare

6.09 2.18

Overview

Share price change

24h

Current

Min

5.87

Max

6.33

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+49.75% upside

Dividends

By Dow Jones

Next Earnings

7 maj 2025

News Sentiment

By Acuity

50%

50%

180 / 386 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

Atara Biotherapeutics Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

7 mar 2025, 21:54 UTC

Earnings

Atara Biotherapeutics to Cut Half of Workforce Amid Restructuring

16 sty 2025, 16:17 UTC

Major Market Movers

Atara Shares Sink After FDA Stalls Cancer Treatment

16 sty 2025, 14:31 UTC

Major Market Movers

FDA Rejects Atara's Request to Bring Blood Cancer Treatment to Market

Peer Comparison

Price change

Atara Biotherapeutics Inc Forecast

Price Target

By TipRanks

49.75% upside

12 Months Forecast

Average 9 USD  49.75%

High 17 USD

Low 3 USD

Based on 5 Wall Street analysts offering 12 month price targets forAtara Biotherapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

5 ratings

2

Buy

3

Hold

0

Sell

Technical Score

By Trading Central

5.85 / 6.54Support & Resistance

Short Term

Very Strong Bearish Evidence

Intermediate Term

Strong Bearish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

180 / 386 Ranking in Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

$